World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
91
Citations
28788
World Ranking
654
National Ranking
17

Medicine

D-Index
91
Citations
29351
World Ranking
11791
National Ranking
159

Laurent Kaiser publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Laurent Kaiser sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 441 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Laurent Kaiser D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Laurent Kaiser sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 91 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Laurent Kaiser is affiliated with Hôpitaux Universitaires de Genève in Switzerland, focusing primarily on medical research in the field of infectious diseases. Their work spans multiple subfields including infectious diseases, epidemiology, modeling and simulation, neurology, and immunology.

The scientist has contributed extensively to research on SARS-CoV-2 and COVID-19, with particular emphasis on COVID-19 clinical research studies, SARS-CoV-2 detection and testing, respiratory viral infections research, epidemiological studies related to COVID-19, and the long-term effects of COVID-19. There is also a notable involvement in HIV/AIDS research and interventions.

Laurent Kaiser's recent publications include:

  • Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study, 2020, The Lancet
  • Novel SARS-CoV-2 variants: the pandemics within the pandemic, 2021, Clinical Microbiology and Infection
  • Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2, 2022, Nature Medicine
  • Long-term consequences of COVID-19: research needs, 2020, The Lancet Infectious Diseases
  • Clinical features of covid-19, 2020, BMJ

Frequent co-authors collaborating with Laurent Kaiser include:

  • Sabine Yerly
  • Isabella Eckerle
  • Enos Bernasconi
  • Alexandra Calmy
  • Huldrych F. Günthard

The scientist has published numerous articles in various academic venues, notably:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Clinical Microbiology and Infection
  • Open Forum Infectious Diseases
  • The Journal of Infectious Diseases

The main field of study for Laurent Kaiser is medicine, with 593 publications linked to this domain. Within this, the highest volume of publications pertains to infectious diseases, followed by epidemiology and specialized areas such as modeling and simulation, neurology, and immunology.

Best Publications

  • Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.

    Silvia Stringhini;Silvia Stringhini;Silvia Stringhini;Ania Wisniak;Giovanni Piumatti;Giovanni Piumatti;Andrew S Azman;Andrew S Azman

  • Influenza virus neuraminidase inhibitors

    Larisa V Gubareva;Laurent Kaiser;Frederick G Hayden

  • Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

    Laurent Kaiser;Cynthia Wat;Tracy Mills;Paul Mahoney

  • Transmission of antiretroviral-drug-resistant HIV-1 variants

    S Yerly;L Kaiser;E Race;J P Bru

  • Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2

    Unknown

  • Beyond malaria : causes of fever in outpatient tanzanian children

    Valérie D'Acremont;Mary Kilowoko;Esther Kyungu;Sister Philipina

  • Picornavirus and enterovirus diversity with associated human diseases

    Caroline Tapparel;Fredy Siegrist;Thomas John Petty Ii;Thomas John Petty Ii;Laurent Kaiser

  • Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

    Selidji T Agnandji;Angela Huttner;Madeleine E Zinser;Patricia Njuguna

  • Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses.

    Laurent Kaiser;R. Scott Fritz;Stephen E. Straus;Larisa Gubareva

  • Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism

    Valeria Cagno;Patrizia Andreozzi;Marco D'Alicarnasso;Paulo Jacob Silva

  • Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.

    Larisa V. Gubareva;Laurent Kaiser;Mikhail N. Matrosovich;Mikhail N. Matrosovich;Yee Soo-Hoo

  • The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge.

    Jean-Christoph Roger J-P Caubet;Laurent Kaiser;Barbara Lemaitre;Benoît Fellay

  • Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study.

    Patrizio Lorenzi;Virginie Masserey Spicher;Birgit Laubereau;Bernard Hirschel

  • Long-term consequences of COVID-19: research needs.

    Dana Yelin;Eytan Wirtheim;Pauline Vetter;Andre C Kalil

  • Novel SARS-CoV-2 variants: the pandemics within the pandemic.

    Erik Boehm;Ilona Kronig;Richard A. Neher;Isabella Eckerle

  • Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data

    Jim Young;An De Sutter;Dan Merenstein;Gerrit A van Essen

  • A Patient with HIV-1 Superinfection

    Stephanie Jost;Marie-Charlotte Bernard;Laurent Kaiser;Sabine Yerly

  • The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

    Angela Huttner;Julie-Anne Dayer;Sabine Yerly;Christophe Combescure

  • Clinical features of covid-19.

    Pauline Vetter;Diem Lan Vu;Diem Lan Vu;Arnaud G L’Huillier;Manuel Schibler;Manuel Schibler

  • Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.

    Patrizio Lorenzi;Milos Opravil;Bernard Hirschel;Jean-Philippe Chave

  • Travel and the spread of HIV-1 genetic variants

    Luc Perrin;Laurent Kaiser;Sabine Yerly

  • Chronic Rhinoviral Infection in Lung Transplant Recipients

    Laurent Kaiser;John-David Aubert;Jean-Claude Pache;Christelle Deffernez

  • Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions

    L Kaiser;D Lew;B Hirschel;R Auckenthaler

  • Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study.

    S Bassetti;M Battegay;H Furrer;M Rickenbach

  • Survival of Influenza Virus on Banknotes

    Yves Thomas;Guido Vogel;Werner Wunderli;Patricia Suter

Frequent Co-Authors

Sabine Yerly
Sabine Yerly University of Geneva
Isabella Eckerle
Isabella Eckerle University of Geneva
Caroline Tapparel
Caroline Tapparel University of Geneva
Claire-Anne Siegrist
Claire-Anne Siegrist University of Geneva
Evgeny M. Zdobnov
Evgeny M. Zdobnov Swiss Institute of Bioinformatics
Didier Pittet
Didier Pittet University of Geneva
Luc Perrin
Luc Perrin University of Geneva
Jacques Fellay
Jacques Fellay École Polytechnique Fédérale de Lausanne
Hansjakob Furrer
Hansjakob Furrer University of Bern
Hans H. Hirsch
Hans H. Hirsch University Hospital of Basel

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career opportunities, many of which benefit from additional health and information management qualifications. For those interested in healthcare administration, exploring a cpc certification can enhance job prospects and provide a solid foundation in medical coding and billing.

Many microbiology graduates pursue advanced education through a master in health information management salary programs, leading to leadership roles that combine scientific expertise with data management. Such roles often require degrees from accredited online health information management degree cahiim programs, ensuring students receive comprehensive training aligned with industry standards.

For those seeking faster entry into the workforce, the availability of fastest online medical billing and coding certificate programs offers a practical pathway to begin a career while continuing education in specialized fields like microbiology. These flexible options allow students to balance studies with work, positioning them for multifaceted career paths in healthcare and research.

Best Scientists Citing Laurent Kaiser

Trending Scientists

Recently Published Articles